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Abstract 
Contagious bovine pleuropneumonia (CBPP) is a respiratory disease caused by Mycoplasma mycoides subsp. mycoides. 
Infection occurs via Mycoplasma-containing droplets and therefore requires close contact between animals. The cur-
rent infection models are suboptimal and based on intratracheal installation of mycoplasmas or in-contact infection. 
This work tested the infection of adult cattle via aerosols containing live mycoplasmas mimicking the infection of 
cattle in the field. Therefore, we infected six cattle with aerosolized Mycoplasma mycoides subsp. mycoides strain Afadé 
over seven consecutive days with altogether  109 colony forming units. All animals seroconverted between 11–24 days 
post infection and five out of six animals showed typical CBPP lesions. One animal did not show any lung lesions at 
necropsy, while another animal had to be euthanized at 25 days post infection because it reached endpoint criteria. 
Seroconversion confirmed successful infection and the spectrum of clinical and lesions observed mirrors epide-
miological models and the field situation, in which only a fraction of animals suffers from acute clinical disease post 
infection.
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Findings
Contagious bovine pleuropneumonia (CBPP) caused 
by Mycoplasma mycoides subsp. mycoides (Mmm) is a 
livestock disease of utmost importance in sub-Saharan 
Africa. Animals get infected by mycoplasma-containing 
droplets, leading to acute or subacute disease that may 
progress into death or chronic malady, although many 
animals recover. Acute disease is characterized by fever, 
pleural effusion, severe respiratory distress and a char-
acteristic cough, with a mortality rate of up to 10% in 
endemic zones [1].
Currently, the control of CBPP in sub-Saharan Africa 
mainly relies on live vaccines (T1/44 and T1sr) that 
have their limitations [2]. In the absence of a meaning-
ful small rodent model for Mmm infections, research 
towards improved vaccines relies on studies involving 
the native host. The current CBPP infection models are 
based on intratracheal intubation accessed via the nasal 
or oral cavity, applied blindly via a flexible rubber tube [3] 
or guided via an bronchoscope [4]. Inoculums reported 
were pleural effusions from CBPP-positive cattle [5], 
which are known to contain high concentrations of 
mycoplasmas [6] or broth cultures containing up to  1010 
mycoplasmas per mL [7]. Alternatively, in contact trans-
mission has been used to infect cattle, which resembles 
the natural infection best, but requires donor animals and 
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model for contagious caprine pleuropneumonia was 
developed, combining aerosol-based intranasal infection 
and intratracheal infection [8]. This work investigated the 
use of aerosols containing mycoplasmas to establish an 
easy to use alternative infection model for CBPP.
Six Boran (Bos indicus) heifers (No. 1–6) aged 
28–37  months at the time of inoculation, weighing 
200–260 kg were enrolled in this study. The sample size 
was determined based on an expectation of 100% mor-
bidity induced by Mmm Afadé. We calculated an exact 
95% confidence interval around the observed 100% (6/6 
animals) morbidity, which indicates a lower limit of 
55%, hence we are 95% confident that the true morbid-
ity is at least 55%. The animals were sourced from CBPP-
free regions in Kenya. The cattle were vaccinated twice 
against foot and mouth disease (Fotivax™, Kevevapi, 
Kenya) at 85 and 66 days before infection and dewormed 
using Levafas Drench (Norbrook®, UK) at 40 days before 
infection. All animals tested seronegative for CBPP 
antibodies using cELISA (IDEXX, Montpellier, France) 
and complement fixation test  (CFT) (CIRAD, Mont-
pellier, France). The layout of the challenge is displayed 
in Fig.  1a. Two weeks prior to the experimental infec-
tion, the cattle were transferred to an animal biosafety 
level two facility (ABSL-2), where they were kept in one 
room (25 m2) with the ability to move freely and having 
access to food and water ad libitum. The strain Afadé [9] 
was cultured as described previously [10], aliquoted and 
stored at − 80 °C until further use. For the experimental 
aerosol infection, thawed Mmm cultures (5  mL, 5 × 108 
colour changing units/mL) were administered equally to 
each nostril using an atomizer (MAD Nasal™ Intranasal 
Mucosal Atomization Device, Teleflex®, USA) connected 
to a lockable glass syringe on seven consecutive days (0–6 
dpi). The droplet size generated by the atomizer ranges 
from 30 to 100 µm. The aerosol was applied during inhal-
ing, took less than 5 min per animal and did not require 
sedation. The health status of the cattle was monitored 
daily in the facility. Rectal temperatures exceeding 39 °C 
were considered as fever. End point criteria were: signs 
of moderate to severe pain, > 3 consecutive days of high 
fever (> 40  °C), lateral recumbency for > 1  day, no feed-
ing for > 4  days, breathing frequency of > 50 breaths per 
minute for > 3 days. The animals were bled twice weekly 
by jugular vein puncture. Whole blood was used imme-
diately for haematological analysis while serum samples 
were stored at −  20  °C until further use. Blood param-
eters were measured using a MEK-6450 Celltac Alpha 
(Nihon Kohden, Japan) according to vendors’ protocol. 
Euthanasia was performed as previously described [3] 
and all necropsies were performed according to stand-
ard procedure [11]. Lung and tracheobronchial as well as 
mediastinal lymph nodes were collected and immediately 
fixed in neutral buffered 10% formalin (Sigma-Aldrich, 
USA) at room temperature until further use. The tissues 
were processed by routine methods and paraffin embed-
ded. Sections of 4  µm were stained with haematoxy-
lin and eosin (HE) for histopathological evaluation. All 
protocols of this study were designed and performed in 
strict accordance with the Kenyan legislation for animal 
experimentation.
Seroconversion was assessed using the CFT [12] and 
the cELISA [13]. The assays and the results interpretation 
were performed according to manufacturer’s instructions 
and the OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals [14]. Detailed information on the use 
of these tests is provided in Additional file 1.
Body temperatures above 39 °C, fever were detected in 
two out of six animals (2 and 6). In 2 the fever peaked 
between 23 and 25 dpi with temperatures ranging from 
40.3 to 40.5 °C, associated with an overall dullness, cough-
ing, extensive nasal discharge and bleeding from the right 
nostril (endpoint criteria). This animal was euthanized 
on 25 dpi. Heifer 6 had mild fever (range 39.1–40.2  °C) 
for eight consecutive days (27–34 dpi), accompanied by 
four days of extensive coughing and inappetence (28–31 
dpi). The animal did however remain with a slight cough 
throughout the study (in total 36 days). Extended periods 
of coughing were also observed in heifers 4 and 5, with 
























Repeated intranasal infection of 6 
adult cattle with aerolsols containing 
M. mycoides subsp. mycoides Afadé
Fig. 1 Cartoon displaying the setup of the in vivo trial. a Six outbred 
Boran (Bos indicus) heifers were intranasally infected with aerosols of 
Mycoplasma mycoides subsp. mycoides strain Afadé on 7 consecutive 
days and kept up to 55 days post infection. b The dashed green line 
displays the numbers of live animals (only heifer 2 reached endpoint 
criteria 25 days post infection). The orange and blue bars represent 
the numbers of animals seroconverted after infection according to 
the complement fixation test and cELISA, respectively
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respectively. For heifer 3, cough was only recorded occa-
sionally. The haematological analysis did not reveal any 
specific findings (data not shown).
At necropsy, pleural fluid appeared normal. All ani-
mals, except heifer 1, had multifocal fibrinous adhesions 
between visceral and parietal pleura. There were multiple 
small consolidated areas in several lung lobes of four ani-
mals (Table 1). In heifer 2, these areas appeared as typical 
lesions of a fibrinous bronchopneumonia with necrosis 
and haemorrhage of the lung tissue and oedema of the 
interlobular septae. In animals 3, 4, and 6, several of these 
lesions were firm. Histopathologically, lung lesions pre-
sented as necrotizing and purulent broncho-interstitial 
pneumonia. Areas of coagulative necrosis and haemor-
rhage of bronchi, bronchioles and adjacent alveoli were 
surrounded by many degenerated neutrophils and few 
lymphocytes, plasma cells and macrophages. In animal 
2, there was marked oedema and fibrin exudation. The 
interlobular septae were inflamed and contained multiple 
fibrin thrombi in lymphatic vessels. Lungs of heifers 3, 4, 
and 6 showed more progressive and chronic lesions with 
areas of necrosis and neutrophil infiltration demarcated 
by prominent, cell rich connective tissue containing large 
lymphocytic cell aggregates (Table 1, Fig. 2). 
Seroconversion results obtained with different tests 
varied, which is expected given the different antibody 
classes detected. According to the CFT, all heifers sero-
converted between 11–24 dpi confirming successful 
infection of all animals. Maximum titres were observed 
around 40–50 dpi, afterwards titres decreased. Sero-
conversion measured by cELISA was observed between 
11–39 dpi for 5 out of 6 heifers. All results are summa-
rized in Additional file 1. Figure 1b shows the dynamics 
of the serological response.
Development of an easy to use and reproducible infec-
tion model for CBPP has remained one of the major 
challenges in CBPP vaccine research for years [2]. The 
infection model tested here builds on the repeated infec-
tion via aerosols and the synchronic inoculation of all 
animals by a defined mycoplasma dose per animal. In 
contrast to the excellent aerosol-based Mycoplasma bovis 
infection model reported recently [15], the model pre-
sented here does not require an infection chamber and 
can be carried out in resource-poor settings. The fact 
that just one animal reached endpoint criteria is not sur-
prising as mortality rates of CBPP in the field range from 
10 to 20%. All animals infected were prime animals origi-
nally intended for breeding purposes without any previ-
ous disease record. The pathomorphological changes 
observed in the five heifers are in agreement to previous 
findings [16] and textbook knowledge [17]. One animal 
seroconverted but did not show any lesions 54 dpi.
Intubation is technically demanding. It requires the 
animals to be sedated and the procedure can be done 
on standing animals or in lateral recumbency. In most 
published studies, intubation is performed once, even if 
repeated intubation over three days were reported [18]. 
Seroconversion happens earlier in intubated than in 
Table 1 Summary of clinical and pathological findings
† Day of euthanasia; dpi: days post infection
Heifer number Clinical signs Macroscopic findings Histopathological findings
1 (†54 dpi) None None None
2 (†25 dpi) Cough, fever Fibrous adhesion: At right diaphragmatic lobe Necrotizing and suppurative broncho-interstitial pneu-
monia, entire lobuli affected, extension of necrosis to 
adjacent lobuli, oedema, fibrin exudation and suppura-
tive inflammation in interlobular septae, fibrin thrombi 
in interlobular lymphatics, beginning fibrosis at margins 
of lesions
Sequester: Seven (1–2 cm in diameter) in right and left 
diaphragmatic lobe
3 (†53 dpi) None Fibrous adhesion: Between left middle and caudal lobe
Between caudal lobe and parietal pleura
Necrotizing and suppurative broncho-interstitial pneumo-
nia, entire lobuli affected, thick, cell rich fibrous connec-
tive tissue capsule formation in interlobular septae with 
lymphocytic infiltration
Sequester: Two (0.5 and 5 cm in diameter) in left middle 
and caudal lobe
One (3 cm in diameter) in right diaphragmatic lobe
4 (†54 dpi) Cough Fibrous adhesion: Between left caudal lobe and parietal 
pleura
Necrotizing and suppurative broncho-interstitial pneumo-
nia, entire lobuli affected
Sequester: One (3 cm in diameter) in left caudal lobe Thick, cell rich fibrous connective tissue capsule formation 
in interlobular septae with lymphocytic infiltration
5 (†55 dpi) Cough Fibrous adhesion: At right caudal lobe None
6 (†55 dpi) Cough, fever Fibrous adhesion: Multiple at all lung lobes Necrotizing and suppurative broncho-interstitial pneumo-
nia, entire lobuli affected
Sequester: Seven (3–12 cm in diameter) in all lung lobes Thick, cell rich fibrous connective tissue capsule formation 
in interlobular septae with lymphocytic infiltration
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in-contact infection [19]. This study confirmed a rather 
overall late seroconversion in the infection model used 
here compared to intubated animals [3, 10].
In-contact infection resembles the natural way of dis-
ease transmission. Drawbacks of the in-contact challenge 
model are: (i) it requires an extra group of diseased ani-
mals as source of infection to be mingled with the ani-
mals to be tested, (ii) efficient transmission happened at 
a ratio of one infected animal per two naïve animals (1:2), 
(iii) the onset of infection is different as in the natural 
setting, making it difficult to compare disease outcomes 
such as clinical signs and lesions. Therefore, this model 
requires many animals to provide meaningful data, which 
is very costly and not in line with 3R guidelines. The pre-
sent study revealed that the repeated intranasal infection 
with an aerosolized culture of Mmm Afadé caused CBPP. 
This easy to use experimental infection model avoids an 
“overchallenge” and will foster pathogenicity, virulence 
and vaccine studies in the future.
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Fig. 2 Representative lung lesions and histological findings. a–c Heifer 2 showing lesions typical of fibrinous pneumonia (a). Histologically b, c 
there is central necrosis (asterisks) of airways and alveoli extending into interlobular septae (arrowheads), which show signs of beginning fibrosis. 
d, e Heifer 3 showing more progressed lesions of multifocal fibrinous pneumonia. d Histologically there is a thicker zone of inflammatory infiltrate 
(arrow) surrounding the central necrosis (asterisks) consisting of neutrophils, lymphocytes and macrophages and marked fibrosis affecting the 
interlobular septae surrounding the affected lobuli (arrowheads)
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